Literature DB >> 8208540

Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.

J Zhang1, C C Chang, L Lombardi, R Dalla-Favera.   

Abstract

Rearrangements of the NFKB2 gene are associated with lymphoid malignancies, but the functional significance of these alterations is not known. Here we characterize structurally and functionally a rearranged NFKB2 gene identified at the T cell lymphoma line, HUT78. The rearrangement has truncated NFKB2 sequences within the 3' ankyrin domain, leading to the production of truncated mRNA species and proteins as detected by Northern blot and immunoprecipitation analysis, respectively. Cloning and sequencing of the corresponding cDNAs indicates that, via alternative splicing, the rearranged gene codes for two proteins of 84 and 85 kD (p84/85) which retain the DNA-binding rel domain and the first five ankyrin repeats, but have lost their carboxy-terminus including the seventh ankyrin repeat. Immunofluorescence and immunoprecipitation analysis of HUT78 cells indicate that p84/85 are abnormally located in the nucleus in an unprocessed form, suggesting that these proteins can escape the cytoplasmic retention typical of the normal NFKB2 p100 protein before it is processed into p52. Electrophoretic mobility shift assays performed on HUT78 nuclear extracts indicate that the abnormal NFKB2 proteins bind kappa B sites specifically and alter the composition of NF-kappa B complexes in HUT78 cells. Transient co-transfection assays involving NFKB2 expression vectors and kappa B-driven reporter plasmids indicate that NFKB2 p85 has lost the transcriptional repressor functions typical of normal NFKB2 p52. These data indicate that the NFKB2 gene rearrangement detected in HUT78 cells leads to the production of abnormal NFKB2 proteins capable of altering the function of the NF-kappa B transcription system. Since analogous rearrangements are found in lymphoid malignancies, these findings further support a role of NFKB2 alterations in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208540

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-15       Impact factor: 11.205

Review 2.  NFκB function and regulation in cutaneous T-cell lymphoma.

Authors:  Tzu-Pei Chang; Ivana Vancurova
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

3.  Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.

Authors:  Rebecca Kohnken; Jing Wen; Bethany Mundy-Bosse; Kathleen McConnell; Ashleigh Keiter; Leah Grinshpun; Alex Hartlage; Max Yano; Betina McNeil; Nitin Chakravarti; Basem William; James E Bradner; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

4.  Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.

Authors:  D W White; G A Pitoc; T D Gilmore
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Authors:  B K Chen; M B Feinberg; D Baltimore
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site.

Authors:  N Azimi; K Brown; R N Bamford; Y Tagaya; U Siebenlist; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  Structural and functional characterization of the promoter regions of the NFKB2 gene.

Authors:  L Lombardi; P Ciana; C Cappellini; D Trecca; L Guerrini; A Migliazza; A T Maiolo; A Neri
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

Review 8.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

9.  Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.

Authors:  Zhe Wang; Baochun Zhang; Liqun Yang; Jane Ding; Han-Fei Ding
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

10.  Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

Authors:  Alexander Ungewickell; Aparna Bhaduri; Eon Rios; Jason Reuter; Carolyn S Lee; Angela Mah; Ashley Zehnder; Robert Ohgami; Shashikant Kulkarni; Randall Armstrong; Wen-Kai Weng; Dita Gratzinger; Mahkam Tavallaee; Alain Rook; Michael Snyder; Youn Kim; Paul A Khavari
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.